Andrew David Otte

Title: Andrew David Otte: Innovator in Injectable Naltrexone Delivery Systems

Introduction

Andrew David Otte is an accomplished inventor based in West Lafayette, IN (US). He has made significant contributions to the field of pharmaceutical delivery systems, particularly in the development of long-acting formulations for therapeutic agents.

Latest Patents

Otte holds a patent for "Injectable long-acting naltrexone microparticle compositions." This patent focuses on naltrexone sustained release microparticle delivery systems designed for the treatment of diseases that can be ameliorated by naltrexone. The innovative delivery system includes naltrexone encapsulated in biodegradable microparticles, which are administered in a pharmaceutically acceptable vehicle. This advancement has the potential to improve patient compliance and therapeutic outcomes.

Career Highlights

Throughout his career, Otte has worked with notable organizations, including Chong Kun Dang Pharmaceutical Corporation and Purdue Research Foundation. His experience in these institutions has allowed him to refine his expertise in drug formulation and delivery technologies.

Collaborations

Otte has collaborated with esteemed colleagues such as Gwangheum Yoon and Bong Kwan Soh. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Andrew David Otte is a notable inventor whose work in injectable naltrexone delivery systems exemplifies innovation in pharmaceutical sciences. His contributions are paving the way for improved treatment options in the medical field.